CN100556446C - The Chinese medicine of treatment hepatocarcinoma - Google Patents
The Chinese medicine of treatment hepatocarcinoma Download PDFInfo
- Publication number
- CN100556446C CN100556446C CNB2007100720568A CN200710072056A CN100556446C CN 100556446 C CN100556446 C CN 100556446C CN B2007100720568 A CNB2007100720568 A CN B2007100720568A CN 200710072056 A CN200710072056 A CN 200710072056A CN 100556446 C CN100556446 C CN 100556446C
- Authority
- CN
- China
- Prior art keywords
- rhizoma
- parts
- radix
- chinese medicine
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The Chinese medicine of treatment hepatocarcinoma, it relates to a kind of Chinese medicine.The objective of the invention is in order to solve the problem that liver cancer patient is performed the operation, radiation and chemotherapy causes very big damage to health.The Chinese medicine of treatment hepatocarcinoma is by ratio of weight and the number of copies by 10-20 part Eupolyphaga Seu Steleophaga among the present invention, 10-20 part Scorpio, 10-20 part stir-baked SQUAMA MANITIS, 5-15 part Scolopendra, 10-20 part Nidus Vespae, 10-20 part Rhizoma Corydalis, 10-15 part Rhizoma Zingiberis Recens worm, 5-15 part rhizoma sparganic, 5-15 part Rhizoma Curcumae, 15-20 part Radix Scrophulariae, 15-20 part Spica Prunellae, 10-20 part Rhizoma Paridis, 10-15 part Spina Gleditsiae, 10-15 part Pericarpium Citri Reticulatae Viride, 10-20 part Concha Ostreae, the Gekko Swinhonis of 10-15 part, 0.5-2 part Mylabris, 10-20 part Bulbus Fritillariae Cirrhosae, 20-30 part Radix Notoginseng, 15-30 part Pseudobulbus Bletillae (Rhizoma Bletillae), 10-20 part Radix Ranunculi Ternati, 5-15 part Pseudobulbus cremastrae seu pleiones, 15-20 part Hirudo, 10-20 part Sanguis Draxonis, 20-30 part Carapax Trionycis, 10-20 part Herba Lobeliae Sessilifoliae, 10-20 part dry maxima skin, 20-30 part Radix Astragali, 20-30 part Herba Artemisiae Scopariae, 10-20 part Radix Bupleuri, making of 15-20 part Herba Solani Nigri and 15-20 part Herba Solani Lyrati.This can bright dispersing tumor anticancer, and total effective rate can reach 96.7%, and total cure rate can reach more than 63.4%.
Description
Technical field
The present invention relates to a kind of Chinese medicine.
Background technology
Serious day by day along with environmental pollution, people are subjected to the influence (as smoking, excessive drinking, ionizing radiation, daylight and ultraviolet radiation, air pollution) of factors such as chemistry, physics, biology, and the sickness rate of cancer is more and more higher.Wherein hepatocarcinoma is one of China's common cancer.The mortality rate height is only second to gastric cancer, esophageal carcinoma and occupies the 3rd in the dead cis-position of malignant tumor, partly then accounting for second in the geographic rural area.China dies from about 110,000 people of hepatocarcinoma every year, accounts for 45% of whole world PLC mortality number.Modern medicine mainly adopts operation, radiation and chemotherapy to treatment for cancer, but the equal defectiveness of these methods, wherein has only the early stage patient treatment that just can undergo surgery, operative treatment is the means of topical therapeutic, like water off a duck's back to the tumor cell of transferring in blood or other tissue, put, chemotherapy can effectively kill and wound cancerous cell, but can kill and wound normal cell again and cause patient's immunologic function to be suppressed simultaneously, more complication occurs, bring very big damage to patient body.The Chinese medicine of some treatment hepatocarcinoma is also arranged now, but all be, can not actually play the effect of anticancer dispersing tumor based on pain relieving, relief of symptoms.
Summary of the invention
The method that the objective of the invention is in order to solve existing operation, radiation and chemotherapy is big to the human injury in treatment hepatocarcinoma process, and a kind of Chinese medicine for the treatment of hepatocarcinoma that provides.The Chinese medicine of treatment hepatocarcinoma is by ratio of weight and the number of copies by 10-20 part Eupolyphaga Seu Steleophaga, 10-20 part Scorpio, 10-20 part stir-baked SQUAMA MANITIS, 5-15 part Scolopendra, 10-20 part Nidus Vespae, 10-20 part Rhizoma Corydalis, 10-15 part Rhizoma Zingiberis Recens worm, 5-15 part rhizoma sparganic, 5-15 part Rhizoma Curcumae, 15-20 part Radix Scrophulariae, 15-20 part Spica Prunellae, 10-20 part Rhizoma Paridis, 10-15 part Spina Gleditsiae, 10-15 part Pericarpium Citri Reticulatae Viride, 10-20 part Concha Ostreae, the Gekko Swinhonis of 10-15 part, 0.5-2 part Mylabris, 10-20 part Bulbus Fritillariae Cirrhosae, 20-30 part Radix Notoginseng, 15-30 part Pseudobulbus Bletillae (Rhizoma Bletillae), 10-20 part Radix Ranunculi Ternati, 5-15 part Pseudobulbus cremastrae seu pleiones, 15-20 part Hirudo, 10-20 part Sanguis Draxonis, 20-30 part Carapax Trionycis, 10-20 part Herba Lobeliae Sessilifoliae, 10-20 part dry maxima skin, 20-30 part Radix Astragali, 20-30 part Herba Artemisiae Scopariae, 10-20 part Radix Bupleuri, 15-20 part Herba Solani Nigri and 15-20 part Herba Solani Lyrati are made.The present invention is the Chinese medicine of pure natural, has no side effect, and can not cause damage to human body.By clinical use, the present invention all has significant curative effect to the treatment of hepatocarcinoma, liver cirrhosis, and is effective, and total effective rate is 96.7%, and total cure rate is more than 63.4%.
Chinese medicine of the present invention is with drastically removing blood stasis and resolving static blood, analgesic antiphlogistic, and the hemopoietic QI invigorating is that theoretical basis is organized medicine, its usage is, is ground to fine flour, crosses 90-120 mesh sieve mixing, after the aseptic sterilization, incapsulates.Oral, every day three times, each 3-5 grain, every heavy 0.5g.1 month is 1 course of treatment.
The present invention be particularly useful for some be not suitable for performing the operation and put, the patient of chemotherapy or recurrence after operation.
Chinese crude drug Eupolyphaga Seu Steleophaga of the present invention (Eupolyphaga Seu Steleophaga, eupolyphaga)---function cures mainly: removing blood stasis with potent drugs blood, reuniting the fractured tendons and bones.Be used for the muscles and bones folding and hinder blood stasis amenorrhea ， mass in the abdomen mass in the abdomen.
Scorpio---function cures mainly: the spasmolytic that relieves dizziness, high fever, infantile convulsions, epilepsy, etc., antiinflammatory counteracting toxic substances, removing obstruction in the collateral to relieve pain.
Stir-baked SQUAMA MANITIS (process of preparing Chinese medicine Squama Manis)---function cures mainly: the stimulating milk secretion of stimulating the menstrual flow, detumescence and apocenosis, expel wind to dredge collateral.Be used for Jing Bi WEIJIA, galactostasis, carbuncle sore tumefacting virus, arthralgia, numbness contracture.
Scolopendra---function cures mainly: dispel the wind arresting convulsion, counteracting toxic substances, eliminating stagnation.
Nidus Vespae---function cures mainly: dispel the wind counteracting toxic substances, parasite killing.
Rhizoma Corydalis---function cures mainly: invigorate blood circulation, dissipating blood stasis is regulated the flow of vital energy, pain relieving.Control all pains of trusted subordinate's waist knee joint, menoxenia ， WEIJIA, metrorrhagia, puerperal blood faints, lochiorrhea, traumatic injury.
Bombyx Batryticatus---function cures mainly: expelling wind for relieving convulsion, dissipating phlegm and resolving masses.Be used for convulsion with spasms, laryngopharynx swelling and pain, submandibular lymph nodes inflammation, facial paralysis, skin pruritus.
Rhizoma sparganic---function cures mainly: removing blood stasis circulation of qi promoting, removing food stagnancy pain relieving.Yong Yu mass in the abdomen mass in the abdomen, blood stasis amenorrhea, food stagnation distending pain literary composition.
Rhizoma Curcumae---function cures mainly: circulation of qi promoting removing blood stasis, removing food stagnancy pain relieving.
Radix Scrophulariae---function cures mainly: YIN nourishing, pathogenic fire reducing, relieving restlessness, detoxifcation.
Spica Prunellae---function cures mainly: relieve inflammation or internal heat, make eye bright, eliminating stagnation, detumescence.Be used for conjunctival congestion and swelling pain, order pearl nyctalgia, it is dizzy to have a headache, scrofula, goiter, acute mastitis swells and ache; Thyromegaly, tuberculous lymphadenitis, cyclomastopathy, hypertension.
Rhizoma Paridis---function cures mainly: heat-clearing and toxic substances removing, and antiasthmatic-antitussive, arresting convulsion relieves dizziness, high fever, infantile convulsions, epilepsy, etc.
Spina Gleditsiae---function cures mainly: search wind, draw out pus by applying a plaster to the affected part, detumescence, evacuation of pus.
Pericarpium Citri Reticulatae Viride---function cures mainly: soothing the liver dispelling the stagnated QI, eliminating stagnation expectorant.
Concha Ostreae---function cures mainly: yin fluid astringing, and YANG hyperactivity suppressing, hidroschesis, arresting seminal emission reduces phlegm, softening the hard mass.Control dizzy, spontaneous perspiration, night sweat, the seminal emission, stranguria with turbid discharge, metrorrhagia, leukorrhagia, scrofula, goiter.
The Gekko Swinhonis function cures mainly: dispel the wind arresting convulsion, eliminating stagnation, detoxifcation.Control paralysis due to windstroke, severe and migratory arthralgia pain, scrofula, malignant boil.
Mylabris---function cures mainly: counteracting toxic substances, removing blood stasis.
Bulbus Fritillariae Cirrhosae---function cures mainly: the lung moistening eliminating stagnation, antitussive reduces phlegm.Control cough due to consumptive disease, the spitting of blood of spitting, ambition pent-up, consumptive lung disease, lung abscess, goiter, scrofula, sore throat, acute mastitis.
Radix Notoginseng---function cures mainly: hemostasis, dissipating blood stasis, detumescence, analgesic therapy.Control haematemesis, hemoptysis, epistaxis is had blood in stool, dysentery, metrorrhagia, puerperal blood faints, retention of lochia falls and pounces on blood stasis, traumatic hemorrhage, carbuncle pain.
Pseudobulbus Bletillae (Rhizoma Bletillae)---function cures mainly: tonifying the lung, and hemostasis, detumescence, granulation promoting is held back skin ulcer.Control lung and hinder hemoptysis, epistaxis, incised wound is hemorrhage, swollen ulcer drug, ulcer pain, the soup fire is burnt, rhagadia manus et pedis.
Radix Ranunculi Ternati---function cures mainly: control scrofula, pulmonary tuberculosis, malaria.
Pseudobulbus cremastrae seu pleiones---function cures mainly: detumescence, eliminating stagnation is reduced phlegm, detoxifcation.It is swollen to control the carbuncle furuncle, scrofula, and sore throat swells and ache, and Serpentis, worm, mad dog hinder.
Hirudo---function cures mainly: removing blood stasis, removing blood stasis stimulates the menstrual flow.Control blood-retention, lump in the abdomen stomachache is gathered, women's amenorrhea, and blood stasis becomes consumptive disease, injury from falling down, conjunctival congestion with ophthalmalgia, removing nebula.
Sanguis Draxonis---function cures mainly: dissipating blood stasis analgesic therapy, hemostasia and promoting granulation.Control traumatic injury and lose, ecchymoma due to internal injury; Continuous bleeding due to traumatic injury, scrofula, ecthyma unhealed for long time.
Carapax Trionycis---function cures mainly: replenishing YIN and removing heat, suppressing the hyperactive liver to relieve the wind syndrome, hard masses softening and resolving.Control the consumptive fever hectic fever due to YIN-deficiency, stirring of wind due to deficiency of YIN, the malaria with general debility malaria with splenomegaly, the amenorrhea menometrorrhagia, children's shies disease.
Herba Lobeliae Sessilifoliae (Herba Lobeliae Chinensis)---function cures mainly: diuretic, detumescence, detoxifcation.The subcutaneous ulcer of harnessing the Yellow River, bronchitis, cirrhotic ascites, edema expands, has loose bowels, dysentery, snakebite, honeybee stings, the carbuncle furuncle, toxic swelling, eczema, the tinea disease, osteopatia sprain swells and ache.
Dry maxima skin---function cures mainly: heat-clearing and toxic substances removing, diuretic relieving distension.Control carbuncle, toxic swelling, scrofula, tumor, infantile malnutrition abdominal distention, chronic tracheitis.
The Radix Astragali (Radix Astragali)---function cures mainly: give birth to and use: benefit is defended consolidating superficial resistance, inducing diuresis to remove edema, poison holding, granulation promoting.Control spontaneous perspiration, night sweat, arthralgia due to stagnation of blood, edema, carbuncle are not burst or are burst and do not hold back for a long time.Process usefulness: invigorating the spleen and replenishing QI.Control the internal injury overstrain, diarrhea due to hypofunction of the spleen, proctoptosis, deficiency of vital energy blood prostration, metrorrhagia and leukorrhagia, and the disease of all weakness of QI blood deficiency.
Herba Artemisiae Scopariae (Herba Artemisiae Scopariae)---function cures mainly: heat clearing away is sharp to be mixed.Control jaundice due to damp-heat, dysuria, pruritus due to wind pathogen skin ulcer scabies.
Radix Bupleuri---function cures mainly: reconciling superficies and interior, and soothing the liver, yang invigorating.Control alternate attack of chill and fever, fullness in the chest and hypochondriac pain, bitter taste deafness, headache and dizziness, malaria, diarrhea proctoptosis, menoxenia, uterine prolapse.
Herba Solani Nigri---function cures mainly: function cures mainly: heat clearing away, detoxifcation is invigorated blood circulation, detumescence.The treatment skin ulcer, carbuncle, erysipelas, osteopatia sprain, chronic tracheitis, acute nephritis.
Herba Solani Lyrati---function cures mainly: heat clearing away, dampness removing dispels the wind, detoxifcation.The treating malaria disease, jaundice, edema, gonorrhea, rheumatic arthritis, erysipelas, furuncle.
The specific embodiment:
The specific embodiment one: the Chinese medicine of present embodiment treatment hepatocarcinoma is by ratio of weight and the number of copies by 10-20 part Eupolyphaga Seu Steleophaga, 10-20 part Scorpio, 10-20 part stir-baked SQUAMA MANITIS, 5-15 part Scolopendra, 10-20 part Nidus Vespae, 10-20 part Rhizoma Corydalis, 10-15 part Rhizoma Zingiberis Recens worm, 5-15 part rhizoma sparganic, 5-15 part Rhizoma Curcumae, 15-20 part Radix Scrophulariae, 15-20 part Spica Prunellae, 10-20 part Rhizoma Paridis, 10-15 part Spina Gleditsiae, 10-15 part Pericarpium Citri Reticulatae Viride, 10-20 part Concha Ostreae, the Gekko Swinhonis of 10-15 part, 0.5-2 part Mylabris, 10-20 part Bulbus Fritillariae Cirrhosae, 20-30 part Radix Notoginseng, 15-30 part Pseudobulbus Bletillae (Rhizoma Bletillae), 10-20 part Radix Ranunculi Ternati, 5-15 part Pseudobulbus cremastrae seu pleiones, 15-20 part Hirudo, 10-20 part Sanguis Draxonis, 20-30 part Carapax Trionycis, 10-20 part Herba Lobeliae Sessilifoliae, 10-20 part dry maxima skin, 20-30 part Radix Astragali, 20-30 part Herba Artemisiae Scopariae, 10-20 part Radix Bupleuri, 15-20 part Herba Solani Nigri and 15-20 part Herba Solani Lyrati are made.
The Chinese medicine of the treatment hepatocarcinoma of present embodiment is with drastically removing blood stasis and resolving static blood, analgesic antiphlogistic, and the hemopoietic QI invigorating is that theoretical basis is organized medicine.Chinese medicine powder in the present embodiment can be broken into less than mix homogeneously behind the 90-120 purpose powder, after the aseptic sterilization, take after incapsulating by 0.5g/ grain medicated powder amount.
Usage and dosage: oral, every day three times, each 3-5 grain.3 months is 1 course of treatment.Contraindication in pregnancy.
The specific embodiment two: the Chinese medicine of present embodiment treatment cancer is by ratio of weight and the number of copies by 11-19 part Eupolyphaga Seu Steleophaga, 11-19 part Scorpio, 11-19 part stir-baked SQUAMA MANITIS, 6-14 part Scolopendra, 11-19 part Nidus Vespae, 11-19 part Rhizoma Corydalis, 10.5-14.5 part Rhizoma Zingiberis Recens worm, 6-14 part rhizoma sparganic, 6-14 part Rhizoma Curcumae, 15.5-19.5 portion Radix Scrophulariae, 15.5-19.5 part Spica Prunellae, 11-19 part Rhizoma Paridis, 10.5-14.5 part Spina Gleditsiae, 10.5-14.5 part Pericarpium Citri Reticulatae Viride, 11-19 part Concha Ostreae, 10.5-14.5 part Gekko Swinhonis, 0.7-1.9 part Mylabris, 11-19 part Bulbus Fritillariae Cirrhosae, 21-29 part Radix Notoginseng, 18-28 part Pseudobulbus Bletillae (Rhizoma Bletillae), 11-19 part Radix Ranunculi Ternati, 6-14 part Pseudobulbus cremastrae seu pleiones, 15.5-19.5 part Hirudo, 11-19 part Sanguis Draxonis, 21-29 part Carapax Trionycis, 11-19 part Herba Lobeliae Sessilifoliae, 11-19 part dry maxima skin, 21-29 part Radix Astragali, 21-29 part Herba Artemisiae Scopariae, 11-19 part Radix Bupleuri, 16.5-19.5 part Herba Solani Nigri and 16.5-19.5 part Herba Solani Lyrati are made.
The specific embodiment three: the Chinese medicine of present embodiment treatment cancer is by ratio of weight and the number of copies by 12-18 part Eupolyphaga Seu Steleophaga, 12-18 part Scorpio, 12-18 part stir-baked SQUAMA MANITIS, 7-13 part Scolopendra, 12-18 part Nidus Vespae, 12-18 part Rhizoma Corydalis, 11-14 part Rhizoma Zingiberis Recens worm, 7-13 part rhizoma sparganic, 7-13 part Rhizoma Curcumae, 16-19 part Radix Scrophulariae, 16-19 part Spica Prunellae, 12-18 part Rhizoma Paridis, 11-14 part Spina Gleditsiae, 11-14 part Pericarpium Citri Reticulatae Viride, the Gekko Swinhonis of 12-18 part Concha Ostreae 11-14 part, 0.9-1.8 part Mylabris, 12-18 part Bulbus Fritillariae Cirrhosae, 22-28 part Radix Notoginseng, 19-27 part Pseudobulbus Bletillae (Rhizoma Bletillae), 12-18 part Radix Ranunculi Ternati, 7-13 part Pseudobulbus cremastrae seu pleiones, 16-19 part Hirudo, 12-18 part Sanguis Draxonis, 22-28 part Carapax Trionycis, 12-18 part Herba Lobeliae Sessilifoliae, 12-18 part dry maxima skin, 22-28 part Radix Astragali, 22-28 part Herba Artemisiae Scopariae, 12-18 part Radix Bupleuri, 16-19 part Herba Solani Nigri and 16-19 part Herba Solani Lyrati are made.
The specific embodiment four: the Chinese medicine of present embodiment treatment cancer is by ratio of weight and the number of copies by 13-17 part Eupolyphaga Seu Steleophaga, 13-17 part Scorpio, 13-17 part stir-baked SQUAMA MANITIS, 8-12 part Scolopendra, 13-17 part Nidus Vespae, 13-17 part Rhizoma Corydalis, 11.5-13.5 part Rhizoma Zingiberis Recens worm, 8-12 part rhizoma sparganic, 8-12 part Rhizoma Curcumae, 16.5-18.5 portion Radix Scrophulariae, 16.5-18.5 part Spica Prunellae, 13-17 part Rhizoma Paridis, 11.5-13.5 part Spina Gleditsiae, 11.5-13.5 part Pericarpium Citri Reticulatae Viride, 13-17 part Concha Ostreae, 11.5-13.5 part Gekko Swinhonis, 1-1.7 part Mylabris, 13-17 part Bulbus Fritillariae Cirrhosae, 23-27 part Radix Notoginseng, 20-26 part Pseudobulbus Bletillae (Rhizoma Bletillae), 13-17 part Radix Ranunculi Ternati, 8-12 part Pseudobulbus cremastrae seu pleiones, 16.5-18.5 part Hirudo, 13-17 part Sanguis Draxonis, 23-27 part Carapax Trionycis, 13-17 part Herba Lobeliae Sessilifoliae, 13-17 part dry maxima skin, 23-27 part Radix Astragali, 23-27 part Herba Artemisiae Scopariae, 13-17 part Radix Bupleuri, 16.5-18.5 part Herba Solani Nigri and 6.5-18.5 part Herba Solani Lyrati are made.
The specific embodiment five: the Chinese medicine of present embodiment treatment cancer is by ratio of weight and the number of copies by 14-16 part Eupolyphaga Seu Steleophaga, 14-16 part Scorpio, 14-16 part stir-baked SQUAMA MANITIS, 9-13 part Scolopendra, 14-16 part Nidus Vespae, 14-16 part Rhizoma Corydalis, 12-13 part Rhizoma Zingiberis Recens worm, 9-11 part rhizoma sparganic, 9-11 part Rhizoma Curcumae, 17-18 part Radix Scrophulariae, 17-18 part Spica Prunellae, 14-16 part Rhizoma Paridis, 12-13 part Spina Gleditsiae, 12-13 part Pericarpium Citri Reticulatae Viride, 14-16 part Concha Ostreae, the Gekko Swinhonis of 12-13 part, 1.2-1.6 part Mylabris, 14-16 part Bulbus Fritillariae Cirrhosae, 24-26 part Radix Notoginseng, 21-25 part Pseudobulbus Bletillae (Rhizoma Bletillae), 14-16 part Radix Ranunculi Ternati, 8-11 part Pseudobulbus cremastrae seu pleiones, 17-18 part Hirudo, 14-16 part Sanguis Draxonis, 24-26 part Carapax Trionycis, 14-16 part Herba Lobeliae Sessilifoliae, 14-16 part dry maxima skin, 24-26 part Radix Astragali, 24-26 part Herba Artemisiae Scopariae, 14-16 part Radix Bupleuri, 17-18 part Herba Solani Nigri and 17-18 part Herba Solani Lyrati are made.
The specific embodiment six: the Chinese medicine of present embodiment treatment cancer is by ratio of weight and the number of copies by 15 parts of Eupolyphaga Seu Steleophagas, 15 parts of Scorpio, 15 parts of stir-baked SQUAMA MANITISs, 10 parts of Scolopendras, 15 parts of Nidus Vespaes, 15 parts of Rhizoma Corydalis, 12 parts of Rhizoma Zingiberis Recens worms, 10 parts of rhizoma sparganic, 10 parts of Rhizoma Curcumae, 17.5 portion Radix Scrophulariae, 17 parts of Spica Prunellaes, 15 parts of Rhizoma Paridis, 12.5 part Spina Gleditsiae, 12.5 part Pericarpium Citri Reticulatae Viride, 15 portions of Concha Ostreaes, 12.5 part Gekko Swinhonis, 1.5 part Mylabris, 15 parts of Bulbus Fritillariae Cirrhosaes, 25 portions of Radix Notoginseng, 23 portions of Pseudobulbus Bletillae (Rhizoma Bletillae)s, 15 portions of Radix Ranunculi Ternatis, 10 parts of Pseudobulbus cremastrae seu pleiones, 17.5 part Hirudo, 15 parts of Sanguis Draxonis, 25 parts of Carapax Trionycis, 15 parts of Herba Lobeliae Sessilifoliae, 15 parts of dry maxima skins, 25 parts of Radixs Astragali, 25 portions of Herba Artemisiae Scopariaes, 15 parts of Radix Bupleuri, 17.5 part Herba Solani Nigri and 17.5 parts of Herba Solani Lyratis are made.
The effect experiment summary:
1, the standard of case selection:
Select clinical manifestation to be divided into the cancer patient of five types and liver cirrhosis patient totally 30 people, wherein 36 years old of the age minimum, maximum 73 years old, 54 years old mean age at random.Tumor body maximum gauge 10cm, minimum 5cm, average 7.7cm; The shortest 1 year of the course of disease, the longest 5 years, average course of disease was the hepatocarcinoma middle and advanced stage.Wherein 28 people have the treatment history.
2, the diagnostic criteria of disease:
Mainly show as hepatalgia, poor appetite, weak, become thin abdominal distention, abdomen piece, heating, the common sympton of jaundice.
3, administrated method:
Oral, every day three times, each four, eliminating cold for resuscitation water is taken.1 month is 1 course of treatment.
4, medication composition:
15 parts of Eupolyphaga Seu Steleophagas, 15 parts of Scorpio, 15 parts of stir-baked SQUAMA MANITISs, 10 parts of Scolopendras, 15 parts of Nidus Vespaes, 15 parts of Rhizoma Corydalis, 12 parts of Rhizoma Zingiberis Recens worms, 10 parts of rhizoma sparganic, 10 parts of Rhizoma Curcumae, 17.5 portion Radix Scrophulariae, 17 parts of Spica Prunellaes, 15 parts of Rhizoma Paridis, 12.5 part Spina Gleditsiae, 12.5 part Pericarpium Citri Reticulatae Viride, 15 portions of Concha Ostreaes, 12.5 part Gekko Swinhonis, 1.5 part Mylabris, 15 parts of Bulbus Fritillariae Cirrhosaes, 25 portions of Radix Notoginseng, 23 portions of Pseudobulbus Bletillae (Rhizoma Bletillae)s, 15 portions of Radix Ranunculi Ternatis, 10 parts of Pseudobulbus cremastrae seu pleiones, 17.5 part Hirudo, 15 parts of Sanguis Draxonis, 25 parts of Carapax Trionycis, 15 parts of Herba Lobeliae Sessilifoliae, 15 parts of dry maxima skins, 25 parts of Radixs Astragali, 25 portions of Herba Artemisiae Scopariaes, 15 parts of Radix Bupleuri, 17.5 part Herba Solani Nigri and 17.5 parts of Herba Solani Lyratis.
5, the criterion of curative effect:
1. cure: the positive sign of symptom and objective determination disappears, and observes year no recidivist half a year to one continuously;
2. produce effects: the tumor body obviously dwindles, and other symptom obviously disappears, and life prolongs;
3. effective: symptom makes moderate progress, and cancer dwindles over half, and other objective determinations take an evident turn for the better;
4. invalid: symptom and objective determination do not have improvement, or only have short-term to improve, and deterioration person rapidly.
6, patient's clinical manifestation of hepatocarcinoma is divided into five types (1958 by the Berman proposition):
1. obvious tumorous type; 2. acute abdomen type; 3. conceal type; 4. fever type; 5. transfevent.
7, efficacy result analysis:
Pairs 30 example ages of table 1 treat at the hepatocarcinoma and the liver cirrhosis patient in 36-73 year, and the survey report that regular hospital provides is accepted and believed in state of an illness diagnosis.
Table 1 (unit: the people)
| Sequence number | Age | Sex | Cancer or symptom | Take this medicine (course of treatment) | Therapeutic effect |
| 1 | 45 | The man | Obvious tumorous type | 2 | Effectively |
| 2 | 42 | The woman | Obvious tumorous type | 3 | Cure |
| 3 | 36 | The man | Obvious tumorous type | 2 | Produce effects |
| 4 | 39 | The man | Obvious tumorous type | 4 | Cure |
| 5 | 38 | The woman | Obvious tumorous type | 3 | Cure |
| 6 | 56 | The man | Obvious tumorous type | 3 | Effectively |
| 7 | 60 | The man | The acute abdomen type | 2 | Effectively |
| 8 | 48 | The woman | The acute abdomen type | 2 | Cure |
| 9 | 60 | The man | The acute abdomen type | 3 | Effectively |
| 10 | 58 | The man | The acute abdomen type | 4 | Produce effects |
| 11 | 49 | The man | The acute abdomen type | 2 | Cure |
| 12 | 49 | The woman | Conceal type | 2 | Cure |
| 13 | 50 | The man | Conceal type | 4 | Cure |
| 14 | 56 | The man | Conceal type | 3 | Effectively |
| 15 | 44 | The man | Conceal type | 2 | Cure |
| 16 | 48 | The man | Conceal type | 4 | Effectively |
| 17 | 44 | The man | Fever type | 3 | Cure |
| 18 | 38 | The man | Fever type | 4 | Cure |
| 19 | 58 | The woman | Fever type | 4 | Cure |
| 20 | 54 | The man | Transfevent | 5 | Cure |
| 21 | 55 | The woman | Transfevent | 5 | Cure |
| 22 | 51 | The man | Transfevent | 2 | Cure |
| 23 | 49 | The man | Transfevent | 2 | Produce effects |
| 24 | 53 | The man | Liver cirrhosis | 4 | Cure |
| 25 | 53 | The woman | Liver cirrhosis | 3 | Cure |
| 26 | 42 | The man | Liver cirrhosis | 3 | Cure |
| 27 | 73 | The man | Liver cirrhosis | 2 | Invalid |
| 28 | 49 | The man | Liver cirrhosis | 3 | Cure |
| 29 | 47 | The woman | Liver cirrhosis | 3 | Cure |
| 30 | 62 | The man | Liver cirrhosis | 4 | Produce effects |
After 2-5 the course of treatment, cure 19 people, account for 63.4%; Produce effects 4 people account for 13.3%; Effective 6 people account for 20%; 1 people that fails to respond to any medical treatment accounts for 3.3%; Total effective rate 96.7%, total cure rate 63.4%.
The clinical proof of the present invention is taken said preparation and can obviously be strengthened patient's body constitution, and appetite obviously strengthens, and the anti-cancer dispersing tumor is taken for a long time and can be suppressed and prevent cytopathy, strengthens immune function of human body, and is free from side effects.
Claims (6)
1, the Chinese medicine of treatment hepatocarcinoma is characterized in that treating the Chinese medicine of hepatocarcinoma by ratio of weight and the number of copies by 10-20 part Eupolyphaga Seu Steleophaga, 10-20 part Scorpio, 10-20 part stir-baked SQUAMA MANITIS, 5-15 part Scolopendra, 10-20 part Nidus Vespae, 10-20 part Rhizoma Corydalis, 10-15 part Rhizoma Zingiberis Recens worm, 5-15 part rhizoma sparganic, 5-15 part Rhizoma Curcumae, 15-20 part Radix Scrophulariae, 15-20 part Spica Prunellae, 10-20 part Rhizoma Paridis, 10-15 part Spina Gleditsiae, 10-15 part Pericarpium Citri Reticulatae Viride, 10-20 part Concha Ostreae, the Gekko Swinhonis of 10-15 part, 0.5-2 part Mylabris, 10-20 part Bulbus Fritillariae Cirrhosae, 20-30 part Radix Notoginseng, 15-30 part Pseudobulbus Bletillae (Rhizoma Bletillae), 10-20 part Radix Ranunculi Ternati, 5-15 part Pseudobulbus cremastrae seu pleiones, 15-20 part Hirudo, 10-20 part Sanguis Draxonis, 20-30 part Carapax Trionycis, 10-20 part Herba Lobeliae Sessilifoliae, 10-20 part dry maxima skin, 20-30 part Radix Astragali, 20-30 part Herba Artemisiae Scopariae, 10-20 part Radix Bupleuri, 15-20 part Herba Solani Nigri and 15-20 part Herba Solani Lyrati are made.
2, the Chinese medicine of treatment hepatocarcinoma according to claim 1 is characterized in that treating the Chinese medicine of hepatocarcinoma by ratio of weight and the number of copies by 11-19 part Eupolyphaga Seu Steleophaga, 11-19 part Scorpio, 11-19 part stir-baked SQUAMA MANITIS, 6-14 part Scolopendra, 11-19 part Nidus Vespae, 11-19 part Rhizoma Corydalis, 10.5-14.5 part Rhizoma Zingiberis Recens worm, 6-14 part rhizoma sparganic, 6-14 part Rhizoma Curcumae, 15.5-19.5 portion Radix Scrophulariae, 15.5-19.5 part Spica Prunellae, 11-19 part Rhizoma Paridis, 10.5-14.5 part Spina Gleditsiae, 10.5-14.5 part Pericarpium Citri Reticulatae Viride, 11-19 part Concha Ostreae, 10.5-14.5 part Gekko Swinhonis, 0.7-1.9 part Mylabris, 11-19 part Bulbus Fritillariae Cirrhosae, 21-29 part Radix Notoginseng, 18-28 part Pseudobulbus Bletillae (Rhizoma Bletillae), 11-19 part Radix Ranunculi Ternati, 6-14 part Pseudobulbus cremastrae seu pleiones, 15.5-19.5 part Hirudo, 11-19 part Sanguis Draxonis, 21-29 part Carapax Trionycis, 11-19 part Herba Lobeliae Sessilifoliae, 11-19 part dry maxima skin, 21-29 part Radix Astragali, 21-29 part Herba Artemisiae Scopariae, 11-19 part Radix Bupleuri, 16.5-19.5 part Herba Solani Nigri and 16.5-19.5 part Herba Solani Lyrati are made.
3, the Chinese medicine of treatment hepatocarcinoma according to claim 1 is characterized in that treating the Chinese medicine of hepatocarcinoma by ratio of weight and the number of copies by 12-18 part Eupolyphaga Seu Steleophaga, 12-18 part Scorpio, 12-18 part stir-baked SQUAMA MANITIS, 7-13 part Scolopendra, 12-18 part Nidus Vespae, 12-18 part Rhizoma Corydalis, 11-14 part Rhizoma Zingiberis Recens worm, 7-13 part rhizoma sparganic, 7-13 part Rhizoma Curcumae, 16-19 part Radix Scrophulariae, 16-19 part Spica Prunellae, 12-18 part Rhizoma Paridis, 11-14 part Spina Gleditsiae, 11-14 part Pericarpium Citri Reticulatae Viride, 12-18 part Concha Ostreae, the Gekko Swinhonis of 11-14 part, 0.9-1.8 part Mylabris, 12-18 part Bulbus Fritillariae Cirrhosae, 22-28 part Radix Notoginseng, 19-27 part Pseudobulbus Bletillae (Rhizoma Bletillae), 12-18 part Radix Ranunculi Ternati, 7-13 part Pseudobulbus cremastrae seu pleiones, 16-19 part Hirudo, 12-18 part Sanguis Draxonis, 22-28 part Carapax Trionycis, 12-18 part Herba Lobeliae Sessilifoliae, 12-18 part dry maxima skin, 22-28 part Radix Astragali, 22-28 part Herba Artemisiae Scopariae, 12-18 part Radix Bupleuri, 16-19 part Herba Solani Nigri and 16-19 part Herba Solani Lyrati are made.
4, the Chinese medicine of treatment hepatocarcinoma according to claim 1 is characterized in that treating the Chinese medicine of hepatocarcinoma by ratio of weight and the number of copies by 13-17 part Eupolyphaga Seu Steleophaga, 13-17 part Scorpio, 13-17 part stir-baked SQUAMA MANITIS, 8-12 part Scolopendra, 13-17 part Nidus Vespae, 13-17 part Rhizoma Corydalis, 11.5-13.5 part Rhizoma Zingiberis Recens worm, 8-12 part rhizoma sparganic, 8-12 part Rhizoma Curcumae, 16.5-18.5 portion Radix Scrophulariae, 16.5-18.5 part Spica Prunellae, 13-17 part Rhizoma Paridis, 11.5-13.5 part Spina Gleditsiae, 11.5-13.5 part Pericarpium Citri Reticulatae Viride, 13-17 part Concha Ostreae, 11.5-13.5 part Gekko Swinhonis, 1-1.7 part Mylabris, 13-17 part Bulbus Fritillariae Cirrhosae, 23-27 part Radix Notoginseng, 20-26 part Pseudobulbus Bletillae (Rhizoma Bletillae), 13-17 part Radix Ranunculi Ternati, 8-12 part Pseudobulbus cremastrae seu pleiones, 16.5-18.5 part Hirudo, 13-17 part Sanguis Draxonis, 23-27 part Carapax Trionycis, 13-17 part Herba Lobeliae Sessilifoliae, 13-17 part dry maxima skin, 23-27 part Radix Astragali, 23-27 part Herba Artemisiae Scopariae, 13-17 part Radix Bupleuri, 16.5-18.5 part Herba Solani Nigri and 6.5-18.5 part Herba Solani Lyrati are made.
5, the Chinese medicine of treatment hepatocarcinoma according to claim 1 is characterized in that treating the Chinese medicine of hepatocarcinoma by ratio of weight and the number of copies by 14-16 part Eupolyphaga Seu Steleophaga, 14-16 part Scorpio, 14-16 part stir-baked SQUAMA MANITIS, 9-13 part Scolopendra, 14-16 part Nidus Vespae, 14-16 part Rhizoma Corydalis, 12-13 part Rhizoma Zingiberis Recens worm, 9-11 part rhizoma sparganic, 9-11 part Rhizoma Curcumae, 17-18 part Radix Scrophulariae, 17-18 part Spica Prunellae, 14-16 part Rhizoma Paridis, 12-13 part Spina Gleditsiae, 12-13 part Pericarpium Citri Reticulatae Viride, 14-16 part Concha Ostreae, the Gekko Swinhonis of 12-13 part, 1.2-1.6 part Mylabris, 14-16 part Bulbus Fritillariae Cirrhosae, 24-26 part Radix Notoginseng, 21-25 part Pseudobulbus Bletillae (Rhizoma Bletillae), 14-16 part Radix Ranunculi Ternati, 8-11 part Pseudobulbus cremastrae seu pleiones, 17-18 part Hirudo, 14-16 part Sanguis Draxonis, 24-26 part Carapax Trionycis, 14-16 part Herba Lobeliae Sessilifoliae, 14-16 part dry maxima skin, 24-26 part Radix Astragali, 24-26 part Herba Artemisiae Scopariae, 14-16 part Radix Bupleuri, 17-18 part Herba Solani Nigri and 17-18 part Herba Solani Lyrati are made.
6, the Chinese medicine of treatment hepatocarcinoma according to claim 1 is characterized in that treating the Chinese medicine of hepatocarcinoma by ratio of weight and the number of copies by 15 parts of Eupolyphaga Seu Steleophagas, 15 parts of Scorpio, 15 parts of stir-baked SQUAMA MANITISs, 10 parts of Scolopendras, 15 parts of Nidus Vespaes, 15 parts of Rhizoma Corydalis, 12 parts of Rhizoma Zingiberis Recens worms, 10 parts of rhizoma sparganic, 10 parts of Rhizoma Curcumae, 17.5 portion Radix Scrophulariae, 17 parts of Spica Prunellaes, 15 parts of Rhizoma Paridis, 12.5 part Spina Gleditsiae, 12.5 part Pericarpium Citri Reticulatae Viride, 15 portions of Concha Ostreaes, 12.5 part Gekko Swinhonis, 1.5 part Mylabris, 15 parts of Bulbus Fritillariae Cirrhosaes, 25 portions of Radix Notoginseng, 23 portions of Pseudobulbus Bletillae (Rhizoma Bletillae)s, 15 portions of Radix Ranunculi Ternatis, 10 parts of Pseudobulbus cremastrae seu pleiones, 17.5 part Hirudo, 15 parts of Sanguis Draxonis, 25 parts of Carapax Trionycis, 15 parts of Herba Lobeliae Sessilifoliae, 15 parts of dry maxima skins, 25 parts of Radixs Astragali, 25 portions of Herba Artemisiae Scopariaes, 15 parts of Radix Bupleuri, 17.5 part Herba Solani Nigri and 17.5 parts of Herba Solani Lyratis are made.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2007100720568A CN100556446C (en) | 2007-04-19 | 2007-04-19 | The Chinese medicine of treatment hepatocarcinoma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2007100720568A CN100556446C (en) | 2007-04-19 | 2007-04-19 | The Chinese medicine of treatment hepatocarcinoma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101041043A CN101041043A (en) | 2007-09-26 |
| CN100556446C true CN100556446C (en) | 2009-11-04 |
Family
ID=38806972
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2007100720568A Expired - Fee Related CN100556446C (en) | 2007-04-19 | 2007-04-19 | The Chinese medicine of treatment hepatocarcinoma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100556446C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103977351A (en) * | 2014-05-23 | 2014-08-13 | 李绍礼 | Medicine composition for treating liver cancer |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101411744B (en) * | 2007-10-19 | 2011-04-27 | 李廷树 | Medicament for treating neoplastic disease |
| CN101342338B (en) * | 2008-08-29 | 2011-01-26 | 邵立红 | Medicament for treating hepatopathy |
| CN102228504A (en) * | 2011-06-12 | 2011-11-02 | 李现华 | Formula of anticancer Chinese medicine and process for preparing products of anticancer Chinese medicine |
| CN102302567B (en) * | 2011-08-11 | 2013-04-10 | 毛顺卿 | Stagnation-removing and stasis-removing Chinese patent medicine |
| CN102389559B (en) * | 2011-11-21 | 2012-10-10 | 许从玉 | Traditional Chinese medicine composition and application as radiotherapy sensitizer |
| CN103505500B (en) * | 2013-07-17 | 2015-09-09 | 广州市四顺山中药研发有限公司 | A kind of Chinese medicine composition for the treatment of hepatitis B and preparation method thereof |
| CN104000910A (en) * | 2014-05-30 | 2014-08-27 | 金鑫 | Anti-hepatoma composition and application thereof |
-
2007
- 2007-04-19 CN CNB2007100720568A patent/CN100556446C/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103977351A (en) * | 2014-05-23 | 2014-08-13 | 李绍礼 | Medicine composition for treating liver cancer |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101041043A (en) | 2007-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100417403C (en) | Traditional Chinese medicine for treating cancer | |
| CN100556446C (en) | The Chinese medicine of treatment hepatocarcinoma | |
| CN102258658B (en) | Plaster for invigorating blood circulation and relieving pain | |
| CN101972424B (en) | Traditional Chinese medicine for treating cirrhosis ascites | |
| CN100431577C (en) | Medicine for treating femoral head necrosis and femur neck fracture and preparation method thereof | |
| CN102885997B (en) | Traditional Chinese medicine for treating neurodermatitis | |
| CN102935205B (en) | Traditional Chinese medicine composition for treating mammary gland hyperplasia | |
| CN103405682A (en) | Traditional Chinese medicine for treating gout and preparation method thereof | |
| CN102973892A (en) | Traditional Chinese medicine combination for treating breast cancer | |
| CN101647981B (en) | Drug for treating blood-deficiency and wind-dry type psoriasis | |
| CN104491060A (en) | Tradtional Chinese medicine for preventing relapse of glioma | |
| CN105250961A (en) | Medicine for treating hyperplasia of mammary glands | |
| CN104873602A (en) | Traditional Chinese medicine for treating mammary gland hyperplasia | |
| CN104740036A (en) | Traditional Chinese medicine composition for treating Qi stagnation and blood stasis amenorrhea | |
| CN103223095A (en) | Ointment for treating beriberi | |
| CN104173610B (en) | Traditional Chinese medicine preparation for treating pelvic inflammatory disease and preparation method thereof | |
| CN103816522A (en) | Chinese medicament for treating hyperplasia of mammary glands | |
| CN103893348B (en) | A kind of Chinese medicine ointment for the treatment of radioactive skin injury and preparation method | |
| CN103432508B (en) | Chinese medicinal preparation used for treating stomachache | |
| CN104784496A (en) | Drug for nursing and treating herpes zoster and preparation method of drug | |
| CN104383417A (en) | Medicine for curing breast cancer | |
| CN103721225B (en) | A kind of medicine for the treatment of piriformis syndrome and preparation method thereof | |
| CN104435117A (en) | Traditional Chinese medicine composition for treating lymphangioma | |
| CN104352738A (en) | Ointment for treating beriberi | |
| CN104352968A (en) | Drug for treating cervical spondylosis and lumbar spondylosis and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20091104 Termination date: 20120419 |